Correlation on MRI Features and HER-2 Expression of Breast Cancer

YANG Li; SHI Gaofeng; LIU Hui; ZHOU Tao

doi:10.3971/j.issn.1000-8578.2013.11.013

Cancer Research on Prevention and Treatment > 2013 > 40(11): 1070-1073. > DOI: 10.3971/j.issn.1000-8578.2013.11.013

YANG Li, SHI Gaofeng, LIU Hui, ZHOU Tao. Correlation on MRI Features and HER-2 Expression of Breast Cancer[J]. Cancer Research on Prevention and Treatment, 2013, 40(11): 1070-1073. DOI: 10.3971/j.issn.1000-8578.2013.11.013

Citation:

PDF (1376 KB)

Correlation on MRI Features and HER-2 Expression of Breast Cancer

1. Department of CT/MR, The Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China, 2. Department of Breast Center

More Information

Received Date: August 27, 2012
Revised Date: March 03, 2013

Graphical Abstract

Abstract

Abstract

Objective To investigate the correlations among MRI morphologic feature, the early-phase enhancement rate, apparent diffusion coefficient (ADC) and HER-2 of breast cancer. Methods Sixtythree patients diagnosed as breast cancers by pathologic examination were reviewed, including MRI features and the expression of HER-2. The morphologic features were observed in early phase. The early-phase enhancement rate and the value of ADC were also calculated. All statistical analyses were performed by using SPSS11.5. Results In the cases with breast cancer, the high expression rate of HER-2 had correlation with necrosis, with higher overexpression rate in patients with necrosis than in the others(χ2＝4.257，P＝0.039). The high expression rate of HER-2 had no correlation with the margin(χ2＝0.100，P＝0.921). The expression rate of HER-2 had no correlation with the early-phase enhancement rate(r＝0.159，P＝0.215). The value of ADC had negative correlation with the expression rate of HER-2(r＝-0.366，P＝0.003). Conclusion MRI features can refl ect the expression of HER-2 in breast cancer partly.
- Breast cancer,
- Magnetic resonance imaging(MRI),
- HER-2

FullText(HTML)

References (12)

References

[1]	Xu BH. Breast Cancer[M].Beijing:Peking University Medical Press, 2005:15-8. [徐兵河.乳腺癌[M].北京:北京大学医学出版社, 2005:15-8.]
[2]	Writing group of breast cancer HER2 testing guideline. Breast cancer HER2 testing guidelines[J].Zhonghua Bing Li Xue Za Zhi, 20 06, 35(10):631-3.乳腺癌HER2检测指南》编写组[J].中华病理学杂志, 2006, 35(10):631-3.]
[3]	Zadrozny M, Smolarz B, Romanowicz-Makowska H, et al. Genetic analysis of HER-2/neu gene amplification in paraffin embedded tumour tissue in women with breast cancer[J]. Pol J Pathol, 2002,53(4):189-93.
[4]	Slamon DJ, Clark GM, Wong SG, et al. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene[J].Science,1987,235(4785):177-81.
[5]	Ross JS, Fletcher JA. The HER-2/neu oncogene in breast cancer: prognostic factor, predictive factor,and target for therapy[J]. Oncologist, 1998, 3(4):237-52.
[6]	Wang MQ, Dong M, Xu XY. Relation of MRI features and the expression of immunohistochemistry in breast cancer[J].Yi Xue Ying Xiang Xue Za Zhi,2010,20(8)：1130-3.[王美芹，董珉，徐新宇.乳腺癌MRI表现与免疫组化相关性的初步研究[J].医学影像学杂志, 2010,20(8):1130-3.]
[7]	Disis ML, Schiffman K.Cancer vaccines targeting the HER-2/neu oncogenic protein[J].Semin Oncol, 2001,28(6 Suppl 18):12-20.
[8]	Chen R, Gong SG, Zhang WG,et al.Correlativity study on MRI morphologic features, pathology, and molecular biology of breast cancer[J].Zhonghua Fang She Xue Za Zhi, 2004, 38(6):620-5. [陈蓉,龚水根,张伟国,等.乳腺癌MRI形态学表现与病理、分子生物学相关性研究[J].中华放射学杂志,2004, 38(6):620-5.]
[9]	Furman-Haran E, Degani H ,Kirshenbaum K ,et al. A two-center clinical testing of the 3TP method for contrast enhanced breast MRI. In proceedings of the 9th annual meeting of ISMRM[C]. Glasgow Scotland, 2001:566-9.
[10]	Buadu LD，Murakami J，Murayama S, et al. Patterns of peripheral enhancement in breast masses: correlation of fi ndings on contrast medium enhanced MRI with histologic features and tumor angiogenesis[J]. J Comput Assist Tomogr, 1997, 21 (3):421-30.
[11]	Zou Y, Zhang MM, Wang LJ, et al. Correlative study of enhancement patterns of dynamic contrast-enhanced MRI and angiogenesis in pulmonary carcinoma[J]. Zhonghua Fang She Xue Za Zhi,2003,37(12):1150-5. [邹煜,张敏鸣,王丽君,等. 肺癌 MRI动态增强模式与肿瘤血管生成的相关性研究[J].中华放射学杂志, 2003,37(12):1150-5.]
[12]	Dragowska WH,Warburton C,Yapp DT,et al. Her-2/neu overexpression increases the viable hypoxic cell population within solid tumors without causing changes in tumor vascularization[J]. Mol Cancer Res, 2004,2(11): 606-19.

[1]	LI Yang, YANG Lingling, BAI Yanli, MING Haixia. Effects of Astragalus Polysaccharides on Growth, Metastasis and Cell Cycle of Lewis Lung Cancer in Tumor-bearing Mice with Qi and Yin Deficiency[J]. Cancer Research on Prevention and Treatment, 2018, 45(3): 131-137. DOI: 10.3971/j.issn.1000-8578.2018.17.0220
[2]	ZHANG Yanli, ZHU Shunqin, LIU Yaling, CUI Hongjuan. 恶性黑色素瘤内科治疗研究进展[J]. Cancer Research on Prevention and Treatment, 2014, 41(01): 74-78. DOI: 10.3971/j.issn.1000-8578.2014.01.017
[3]	Zhang Jun, Cao Peiguo, Pan Yuliang. Inhibitory Effects of Quercetin in Combined with Resveratrol on Growth of Lewis Lung Cancer in Mice[J]. Cancer Research on Prevention and Treatment, 2012, 39(08): 936-939. DOI: 10.3971/j.issn.1000-8578.2012.08.013
[4]	Xu yuehua, Zhang guangbo, Wang jiamin, Hu huacheng. Effect of B7-H3 on Growth of Lewis Lung Carcinoma Cell[J]. Cancer Research on Prevention and Treatment, 2012, 39(04): 376-380. DOI: 10.3971/j.issn.1000-8578.2012.04.003
[5]	YANG Kai, HE Jian-bin, ZHANG Ping. Inhibitory Effects of Resveratrol on Growth of Lewis Lung Cancer Cell in Mice and Possible Mechanism[J]. Cancer Research on Prevention and Treatment, 2011, 38(08): 871-874. DOI: 10.3971/j.issn.1000-8578.2011.08.005
[6]	GUO Wei-hua, BIAN Jun-jie, DONG Bo-sheng, ZHANG Yan-fang, LI Xing-ya. Effect of Angiogenesis on Growth and Metastasis of Lewis Lung Carcinoma[J]. Cancer Research on Prevention and Treatment, 2010, 37(04): 378-381. DOI: 10.3971/j.issn.1000-8578.2010.04.003
[7]	YANG Sheng, LU Hui-shan, CHEN Xiang-qi, LIN Ting-yan, LI Zhi-ying, KANG Ming-qiang. Effect of IL-18 on Growth and Apoptosis of Lewis Lung Cancer Xenografts in C57BL/6 Mice[J]. Cancer Research on Prevention and Treatment, 2009, 36(07): 563-565. DOI: 10.3971/j.issn.1000-8578.2009.07.007
[8]	LI Xin, CUI Yong-sheng, LIU Bai-nan, LI Yi. Function of CD4~+CD25~+Treg and Effecter Cells of Mice with Lewis Lung Cancer Were Influenced by CTX and BCG Therapeutic Alliance[J]. Cancer Research on Prevention and Treatment, 2008, 35(10): 694-696. DOI: 10.3971/j.issn.1000-8578.3329
[9]	Wu Tianpeng, . Electron Microscopic Observation on Lewis Lung Cancinoma (LLC) Affacted by Histamine[J]. Cancer Research on Prevention and Treatment, 1997, 24(6): 352-353.
[10]	Xie Jin-wen, . Effects of interferon-αliposome on lung metastasis of Lewis lung carcinoma and proliferation of splenocytes in mice[J]. Cancer Research on Prevention and Treatment, 1996, 23(5): 273-276.

Cited By

Get Citation

PDF

XML

Article views (1777) PDF downloads (599)

Turn off MathJax

Article Contents

Abstract

References

Correlation on MRI Features and HER-2 Expression of Breast Cancer

Abstract

References

Related Articles

Catalog

Contact Us

Correlation on MRI Features and HER-2 Expression of Breast Cancer

Abstract

References

Related Articles

Catalog

Contact Us

Export File

Citation

Format

Content